GDF-15 has been shown to modulate energy balance and glucose homeostasis, and its administration leads to promising beneficial effects against obesity and associated metabolic diseases in pre-clinical models [68]. Here, GDF15 is linked to obesity due to melanocortin 4 receptor deficiency.